We reveal that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD capabilities in a number of human and mouse immune cells; we provide proof in their ability to suppress inflammation in vivo As well as in medical settings; and we offer insights into their mechanism of action. Our conclusions https://johnl530lvd9.angelinsblog.com/profile